Expert Skin Sensitisation Services

Gentronix provides in chemico and in vitro services for investigating key events of the skin sensitisation adverse outcome pathway (AOP). Using this battery of assays enables weight of evidence approaches to be adopted for the hazard assessment of potential skin sensitisers, without the use of laboratory animals. Our team of experts can support you in delivering the correct combination of these assays for your project, along with interpretation of the results with regards to the AOP.